Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
Part of paid clinical trials in Greenville, North Carolina.
- Sponsor
- Thryv Therapeutics, Inc.
- Study ID
- NCT07075445
- Status
- Recruiting
Conditions
- Long QT Syndrome 2
- Long QT Syndrome Type 3
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will answer each patient-reported outcome questionnaire only once over a 6-month period. The study will enroll up to 200 participants.
Key Dates
- Start date
- Oct 27, 2025
- Status verified
- Nov 2025
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
Quality of Life (QoL) [ Time Frame: Month 1 ]
Central Contacts
- Study Coordinator252-955-4157
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| East Carolina University | Greenville | North Carolina | 27858 | - |
Find similar trials in Greenville, NC
By research site